Bimat + Applicators

Basic Bimat + applicators information

• INN (international nonproprietary name): Bimatoprost
• Brand names available in the United Kingdom: Lumigan (0.01% and 0.03%, for glaucoma); Bimat + Applicators and Careprost are not licensed in the UK
• ATC code: S01EE03
• Forms and dosages: Ophthalmic solution 0.03% (Bimat + Applicators, with sterile applicators); Lumigan eye drops 0.01% and 0.03%
• Manufacturers in the United Kingdom: Allergan (AbbVie) for Lumigan
• Registration status in the United Kingdom: Lumigan is licensed by the MHRA for glaucoma; Bimat + Applicators is not licensed in the UK
• OTC / Rx classification: Prescription-only medicine (POM)

Everyday use and best practices

Bimat + Applicators is used once daily on the upper eyelid margin, following the instructions of your prescriber.

Morning vs evening dosing

For eyelash growth, bimatoprost is usually applied in the evening, once daily. Use the solution at the same time each night to establish a routine; skipping doses can lead to inconsistent results.

Taking with or without meals

Bimatoprost is an ophthalmic solution, meaning it is applied directly to the eyelashes rather than ingested. Therefore, meals do not affect its absorption or effectiveness. Applying it as part of an evening routine helps to ensure that no doses are missed.

Safety priorities

Who should avoid it

Individuals with a history of hypersensitivity to bimatoprost or any of its components should not use this product. Caution is also advised for those with existing ocular conditions such as active infections or significant intraocular inflammation.

Activities to limit

After applying bimatoprost, certain activities should be limited to prevent any potential complications. Activities that require clear vision, like driving or operating machinery, should be avoided if you have temporary side effects such as blurred vision after application, until your vision is clear.

Dosage and adjustments

General regimen

The typical dosage for eyelash growth is one drop of the 0.03% solution applied to the upper eyelid margin once nightly, using a sterile applicator. For glaucoma (Lumigan), one drop is administered in the affected eye(s) once daily, in the evening. Do not exceed the recommended dose.

Special cases

Elderly patients generally do not require specific dosage adjustments. For individuals with renal or liver issues, bimatoprost should be used cautiously, as insufficient data exists regarding safety and efficacy in these groups.

What’s inside and how it works

Ingredients overview

Bimatoprost is a prostaglandin analogue, which is the key to its eyelash-promoting properties. The formulation also includes preservatives such as benzalkonium chloride. Tell your prescriber if you have had reactions to eye medicines.

Mechanism basics explained simply

Bimatoprost promotes eyelash growth by stimulating the hair follicles. Essentially, it extends the growth phase of eyelashes, allowing them to grow longer and fuller. The prostaglandin analogue interacts with specific receptors in the follicles, leading to enhanced lash density over time. Results typically start to be noticed after about four weeks, with maximal benefits after around 16 weeks.

Main indications

Uses

Bimat + Applicators (bimatoprost 0.03%) is not licensed in the UK. It is used to treat eyelash hypotrichosis (sparse lashes). In the UK, bimatoprost eye drops (Lumigan) are licensed for lowering raised intraocular pressure in glaucoma and ocular hypertension.

Off-label uses

Bimatoprost is sometimes used for enhancing eyebrow density, which is outside any licence. Consult a qualified professional before using bimatoprost for cosmetic enhancement, considering the potential risks alongside the desired benefits.

Interaction warnings

Food interactions

Alcohol may enhance dryness or irritation of the eyes.

Drug conflicts

Using bimatoprost together with other prostaglandin eye drops can reduce the intraocular pressure-lowering effect, and combining it with other eye medicines may increase side effects. Consult your healthcare provider before starting bimatoprost alongside other medicines. Suspected side effects can be reported through the Yellow Card scheme.

Alternative choices

For glaucoma management, NHS-prescribed alternatives include:

• Latanoprost (Xalatan): another prostaglandin analogue effective in lowering intraocular pressure.
• Timolol: a beta-blocker eye drop that lowers intraocular pressure.

Compare effectiveness and side effects with your eye specialist.

Regulation snapshot

Bimat + Applicators is not licensed in the UK. Bimatoprost is a prescription-only medicine (POM), regulated by the Medicines and Healthcare products Regulatory Agency (MHRA); Lumigan is licensed for glaucoma.

Frequently asked questions

Common UK patient questions

• How long before I see results from bimatoprost?
  Results are usually noticed after 4 to 16 weeks of consistent use.
• Are there any permanent side effects?
  Darkening of the iris or eyelid skin may occur, sometimes permanently.
• Can I use bimatoprost with other eye drops?
  Consult your healthcare provider to avoid potential conflicts.
• Is it safe to use during pregnancy?
  Pregnant women should seek medical advice before use as safety is not established.

Guidelines for proper use

Applying Bimatoprost correctly maximises its effectiveness. Here are best practices:

• Use a sterile applicator to place a drop along the upper eyelid margin each night.
• Ensure the area is clean and free from makeup or creams to prevent contamination.
• Wipe away any excess fluid to avoid irritation.

For more detailed guidance, see the patient information leaflet or ask your pharmacist.